EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) UNDER
THE SECURITIES EXCHANGE ACT OF 1934
I, Lance A. Berry, certify that:
1. |
|
I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2011, of
Wright Medical Group, Inc. (the Company); |
2. |
|
Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report; |
3. |
|
Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the Company as of, and for, the periods presented in this report; |
4. |
|
The Companys other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the Company and have: |
|
(a) |
|
designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the Company, including the Companys consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report
is being prepared; |
|
(b) |
|
designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted
accounting principles; |
|
(c) |
|
evaluated the effectiveness of the Companys disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and |
|
(d) |
|
disclosed in this report any change in the Companys internal control over financial
reporting that occurred during the Companys most recent fiscal quarter (the Companys
fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the Companys internal control over financial
reporting; and |
5. |
|
The Companys other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Companys auditors and the
audit committee of the Companys board of directors: |
|
(a) |
|
all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the Companys ability to record, process, summarize and report financial information; and |
|
(b) |
|
any fraud, whether or not material, that involves management or other employees who
have a significant role in the Companys internal control over financial reporting. |
Date:
May 11, 2011
|
|
|
|
|
|
/s/ Lance A. Berry
|
|
|
Lance A. Berry |
|
|
Senior Vice President and
Chief Financial Officer |
|
|